Chao Deng

2.6k total citations · 1 hit paper
47 papers, 1.6k citations indexed

About

Chao Deng is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Chao Deng has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Genetics. Recurrent topics in Chao Deng's work include Diabetes and associated disorders (11 papers), Diabetes Management and Research (9 papers) and Pancreatic function and diabetes (7 papers). Chao Deng is often cited by papers focused on Diabetes and associated disorders (11 papers), Diabetes Management and Research (9 papers) and Pancreatic function and diabetes (7 papers). Chao Deng collaborates with scholars based in China, United States and United Kingdom. Chao Deng's co-authors include Shaoyi Liu, Guoyin Wang, Aili Wang, Fengzhu Sun, Nathan A. Ahlgren, Kai Song, Xiaohui Xie, Yi Li, Ryan Poplin and Jie Ren and has published in prestigious journals such as Nature Biotechnology, Bioinformatics and Diabetes Care.

In The Last Decade

Chao Deng

41 papers receiving 1.6k citations

Hit Papers

Identifying viruses from metagenomic data using deep lear... 2020 2026 2022 2024 2020 100 200 300

Peers

Chao Deng
Hong Yu China
Lesley Heptinstall United Kingdom
Santosh Renuse United States
David W. Montgomery United States
Michael W. Reed United States
Claire Summers United Kingdom
Hong Yu China
Chao Deng
Citations per year, relative to Chao Deng Chao Deng (= 1×) peers Hong Yu

Countries citing papers authored by Chao Deng

Since Specialization
Citations

This map shows the geographic impact of Chao Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Deng more than expected).

Fields of papers citing papers by Chao Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Deng. The network helps show where Chao Deng may publish in the future.

Co-authorship network of co-authors of Chao Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Deng. A scholar is included among the top collaborators of Chao Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Deng. Chao Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jianguo, Yuxin Mu, Hui Zhang, et al.. (2025). Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer in first-line/second-line setting. Frontiers in Oncology. 15. 1564888–1564888.
2.
Xu, Rui‐Hua, Fan Li, Rui Guo, et al.. (2025). Glycated hemoglobin is not enough: The role of glycemia risk index for glycemic control assessment in type 1 diabetes. World Journal of Diabetes. 16(6). 104024–104024.
3.
Deng, Chao, et al.. (2024). Efficacy and Safety of Automated Insulin Delivery Systems in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes & Metabolism Journal. 49(2). 235–251. 9 indexed citations
4.
Peng, Yani, Yuxin Zhang, Fan Yang, et al.. (2024). Multiply restimulated human cord blood-derived Tregs maintain stabilized phenotype and suppressive function and predict their therapeutic effects on autoimmune diabetes. Diabetology & Metabolic Syndrome. 16(1). 71–71. 2 indexed citations
5.
Yang, Shuhong, et al.. (2023). [Application of the Chinese Expert Consensus on Diabetes Classification in clinical practice].. PubMed. 62(9). 1085–1092. 4 indexed citations
7.
Wu, Fengying, Yue Zeng, Yujun Li, et al.. (2023). 1843MO The effect of chronic psychological stress on the efficacy of first-line therapy of ICIs in advanced NSCLC (STRESS-LUNG-1 trial). Annals of Oncology. 34. S999–S999. 1 indexed citations
8.
Deng, Chao, Xianling Liu, Shun Jiang, et al.. (2023). Case Report: ICIs-induced Guillain–Barré syndrome recovered from mycophenolate mofetil. Frontiers in Immunology. 14. 7 indexed citations
9.
Deng, Chao, Sujuan Zhang, Yuhua Feng, et al.. (2023). Prognostic value of the fibrinogen albumin ratio index (FARI) in nasopharyngeal carcinoma patients undergoing radiotherapy. Scientific Reports. 13(1). 20630–20630. 3 indexed citations
10.
Li, Hong‐Dong, et al.. (2022). AlzCode: a platform for multiview analysis of genes related to Alzheimer’s disease. Bioinformatics. 38(7). 2030–2032. 9 indexed citations
11.
Tan, Tingting, Yufei Xiang, Chao Deng, et al.. (2022). Variable frequencies of peripheral T-lymphocyte subsets in the diabetes spectrum from type 1 diabetes through latent autoimmune diabetes in adults (LADA) to type 2 diabetes. Frontiers in Immunology. 13. 974864–974864. 11 indexed citations
12.
Wang, Zhen, Chao Deng, & Ying Zheng. (2021). Involvement of circRNAs in Proinflammatory Cytokines‐Mediated β‐Cell Dysfunction. Mediators of Inflammation. 2021(1). 5566453–5566453. 14 indexed citations
13.
Xiao, Yangfan, Chao Deng, & Zhiguang Zhou. (2021). The Multiple Roles of B Lymphocytes in the Onset and Treatment of Type 1 Diabetes: Interactions between B Lymphocytes and T Cells. Journal of Diabetes Research. 2021. 1–8. 8 indexed citations
15.
16.
Zhao, Yuan, et al.. (2021). RFCell: A Gene Selection Approach for scRNA-seq Clustering Based on Permutation and Random Forest. Frontiers in Genetics. 12. 665843–665843. 4 indexed citations
18.
Shi, Xiajie, Gan Huang, Yanfei Wang, et al.. (2018). Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA. Diabetologia. 62(3). 399–407. 23 indexed citations
19.
Deng, Chao, Yufei Xiang, Tingting Tan, et al.. (2017). The Imbalance of B-Lymphocyte Subsets in Subjects with Different Glucose Tolerance: Relationship with Metabolic Parameter and Disease Status. Journal of Diabetes Research. 2017. 1–9. 15 indexed citations
20.
Zhang, Jingjing, Lili Ding, Gaiyan Ren, et al.. (2014). Notoginsenoside R1 Attenuates Experimental Inflammatory Bowel Disease via Pregnane X Receptor Activation. Journal of Pharmacology and Experimental Therapeutics. 352(2). 315–324. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026